Taken together, these results demonstrate that PTBP1 up‐regulation is associated with poor response to chemotherapy of osteosarcoma, and higher PTBP1 expression predicts worse prognoses in osteosarcoma patients. Here, PTBP1 is linked to osteosarcoma.